James Healy, Director at Coherus BioSciences, Inc. (CHRS), sold 869,110 shares at $17.17 ($14.5M) on 2021-09-28, disclosed to the SEC on 2021-09-29.
Open-market sale of $14.5M CHRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.06 | 100,150 | $1.8M | 12.5% |
| 2 | $18.06 | 100,150 | $1.8M | 12.5% |
| 3 | $17.17 | 48,329 | $830K | 5.7% |
| 4 | $17.17 | 48,329 | $830K | 5.7% |
| 5 | $16.12 | 286,076 | $4.6M | 31.8% |
| 6 | $16.12 | 286,076 |
| $4.6M |
| 31.8% |
| Total | $16.68 avg | 869,110 | $14.5M | 100% |
| Filing → |
| RAPP | BUY | 2024-06-10 | $9.5M | — | Filing → |
| AVBP | BUY | 2024-01-31 | $8.0M | — | Filing → |
| NTRA | SELL | 2023-12-22 | $37.8M | — | Filing → |